Interlaboratory variation in PD-L1 positivity in non-small cell lung cancer patients: a comparison between histological and cytological material

被引：0
|
作者：
Koomen, B. [1 ]
Voorham, R. [2 ]
Kuijpers, C. [1 ]
Deckers, I. [2 ]
Willems, S. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[2] PALGA Fdn Nationwide Network & Registry Histo & C, Houten, Netherlands
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-10-004
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [11] Factors Influencing Concordance of PD-L1 Expression between Biopsies and Cytological Specimens in Non-Small Cell Lung Cancer
    Mansour, Mohammed S. I.
    Hejny, Kim
    Johansson, Felicia
    Mufti, Joudy
    Vidis, Ante
    Mager, Ulrich
    Dejmek, Annika
    Seidal, Tomas
    Brunnstroem, Hans
    DIAGNOSTICS, 2021, 11 (10)
  • [12] Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer
    Scheel, Andreas H.
    Baenfer, Gudrun
    Baretton, Gustavo
    Dietel, Manfred
    Diezko, Rolf
    Henkel, Thomas
    Heukamp, Lukas C.
    Jasani, Bharat
    Joehrens, Korinna
    Kirchner, Thomas
    Lasitschka, Felix
    Petersen, Iver
    Reu, Simone
    Schildhaus, Hans-Ulrich
    Schirmacher, Peter
    Schwamborn, Kristina
    Sommer, Ulrich
    Stoss, Oliver
    Tiemann, Markus
    Warth, Arne
    Weichert, Wilko
    Wolf, Juergen
    Buettner, Reinhard
    Rueschoff, Josef
    HISTOPATHOLOGY, 2018, 72 (03) : 449 - 459
  • [13] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [14] PREDICTORS OF PD-L1 TESTING IN NON-SMALL CELL LUNG CANCER
    DiBonaventura, M.
    Meyers, A.
    Higginbottom, K.
    Morimoto, Y.
    Ilacqua, J.
    VALUE IN HEALTH, 2016, 19 (07) : A763 - A763
  • [15] Durvalumab for the treatment of PD-L1 non-small cell lung cancer
    Naito, Tomoyuki
    Shiraishi, Hideaki
    Fujiwara, Yutaka
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 95 - 105
  • [16] Current PD-L1 immunohistochemistry for non-small cell lung cancer
    Scheel, Andreas H.
    Schaefer, Stephan C.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1217 - 1219
  • [17] Correlation of PD-L1 Expression with Histological Patterns and Treatment Response in Non-Small Cell Lung Cancer
    Beshai, Boulos
    Xu, Bo
    MODERN PATHOLOGY, 2018, 31 : 724 - 724
  • [18] PD-L1 status in patients of the Moscow region with non-small cell lung cancer
    Byakhova, M.
    Zavalishina, L.
    Andreeva, Y.
    Tsimafeyeu, I.
    Savelov, N.
    Tjulandin, S.
    Frank, G.
    VIRCHOWS ARCHIV, 2020, 477 : S364 - S364
  • [19] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [20] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
12345